Including shipping and handling costs 0001109138 2021-01-01 2021-06-30 0001109138 2020-12-31 0001109138 2021-06-30 0001109138 2020-01-01 2020-06-30 0001109138 2021-04-01 2021-06-30 0001109138 2020-04-01 2020-06-30 0001109138 2020-01-01 2020-12-31 0001109138us-gaap:CommonStockMember 2019-12-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001109138us-gaap:RetainedEarningsMember 2019-12-31 0001109138 2019-12-31 0001109138 2020-03-31 0001109138us-gaap:RetainedEarningsMember 2020-03-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001109138us-gaap:CommonStockMember 2020-03-31 0001109138 2020-06-30 0001109138us-gaap:RetainedEarningsMember 2020-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001109138us-gaap:CommonStockMember 2020-06-30 0001109138us-gaap:RetainedEarningsMember 2020-12-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001109138us-gaap:CommonStockMember 2020-12-31 0001109138 2021-03-31 0001109138us-gaap:RetainedEarningsMember 2021-03-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001109138us-gaap:CommonStockMember 2021-03-31 0001109138us-gaap:RetainedEarningsMember 2021-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001109138us-gaap:CommonStockMember 2021-06-30 0001109138us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001109138 2020-01-01 2020-03-31 0001109138us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001109138us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001109138us-gaap:CommonStockMember 2020-07-01 2020-12-31 0001109138us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001109138us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-12-31 0001109138us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001109138 2020-07-01 2020-12-31 0001109138us-gaap:RetainedEarningsMember 2020-07-01 2020-12-31 0001109138us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001109138 2021-01-01 2021-03-31 0001109138us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001109138us-gaap:TreasuryStockMember 2020-07-01 2020-12-31 0001109138us-gaap:TreasuryStockMember 2020-03-31 0001109138us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001109138us-gaap:TreasuryStockMember 2021-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001109138us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001109138us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001109138us-gaap:TreasuryStockMember 2021-03-31 0001109138us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001109138us-gaap:TreasuryStockMember 2020-12-31 0001109138us-gaap:TreasuryStockMember 2020-06-30 0001109138us-gaap:TreasuryStockMember 2019-12-31 0001109138camt:PriortechLtdMember 2021-06-30 0001109138camt:ChromaAteIncMember 2021-06-30 0001109138us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001109138us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001109138us-gaap:EmployeeStockOptionMember 2021-04-01 2021-06-30 0001109138srt:AsiaPacificMember 2021-01-01 2021-06-30 0001109138srt:AsiaPacificMember 2020-01-01 2020-06-30 0001109138srt:AsiaPacificMember 2021-04-01 2021-06-30 0001109138srt:AsiaPacificMember 2020-04-01 2020-06-30 0001109138srt:AsiaPacificMember 2020-01-01 2020-12-31 0001109138country:US 2021-01-01 2021-06-30 0001109138country:US 2020-01-01 2020-06-30 0001109138country:US 2021-04-01 2021-06-30 0001109138country:US 2020-04-01 2020-06-30 0001109138country:US 2020-01-01 2020-12-31 0001109138srt:EuropeMember 2021-01-01 2021-06-30 0001109138srt:EuropeMember 2020-01-01 2020-06-30 0001109138srt:EuropeMember 2021-04-01 2021-06-30 0001109138srt:EuropeMember 2020-04-01 2020-06-30 0001109138srt:EuropeMember 2020-01-01 2020-12-31 0001109138currency:USD 2021-06-30 0001109138currency:USD 2020-12-31 0001109138currency:ILS 2021-06-30 0001109138currency:ILS 2020-12-31 0001109138currency:EUR 2021-06-30 0001109138currency:EUR 2020-12-31 0001109138currency:XXX 2021-06-30 0001109138currency:XXX 2020-12-31 0001109138us-gaap:LandMember 2021-06-30 0001109138us-gaap:BuildingMember 2021-06-30 0001109138us-gaap:MachineryAndEquipmentMember 2021-06-30 0001109138us-gaap:OfficeEquipmentMember 2021-06-30 0001109138us-gaap:ComputerEquipmentMember 2021-06-30 0001109138us-gaap:AutomobilesMember 2021-06-30 0001109138us-gaap:LeaseholdImprovementsMember 2021-06-30 0001109138camt:RightOfUseAssetsMember 2021-06-30 0001109138us-gaap:LandMember 2020-12-31 0001109138us-gaap:BuildingMember 2020-12-31 0001109138us-gaap:MachineryAndEquipmentMember 2020-12-31 0001109138us-gaap:OfficeEquipmentMember 2020-12-31 0001109138us-gaap:ComputerEquipmentMember 2020-12-31 0001109138us-gaap:AutomobilesMember 2020-12-31 0001109138us-gaap:LeaseholdImprovementsMember 2020-12-31 0001109138camt:RightOfUseAssetsMember 2020-12-31 iso4217:ILSxbrli:shares xbrli:pure xbrli:shares iso4217:USD iso4217:USDxbrli:shares

Exhibit 99.1

 

Camtek Ltd.
and its Subsidiaries

 

Interim Condensed Consolidated
Financial Statements
As of June 30, 2021
(Unaudited)
 

 
Camtek Ltd. and its Subsidiaries
 
Interim Unaudited Condensed Consolidated Financial Statements as at June 30, 2021
 
Contents
 
 
Page
  
F-3
F-4
F-5
F-6
F-7 to F-13

 


 
Camtek Ltd. and its Subsidiaries
Interim Unaudited Condensed Consolidated Balance Sheets

 
         
June 30,
   
December 31,
 
         
2021
   
2020
 
   
Note
   
U.S. Dollars (in thousands)
 
Assets
                 
                   
Current assets
                 
Cash and cash equivalents
 
5A
 
   
80,339
     
105,815
 
Short-term deposits
         
109,000
     
72,000
 
Trade accounts receivable, net
         
60,259
     
41,001
 
Inventories
 
5B
 
   
54,346
     
39,736
 
Other current assets
 
5C
 
   
4,411
     
3,366
 
                       
Total current assets
         
308,355
     
261,918
 
                       
Long term deposits
         
10,000
     
-
 
Long term inventory
 
5B
 
   
4,694
     
4,416
 
Deferred tax assets
         
-
     
482
 
Other assets, net
         
119
     
85
 
Property, plant and equipment, net
 
5D
 
   
20,377
     
20,398
 
Intangible assets, net
 
5E
 
   
602
     
609
 
                       
           
35,792
     
25,990
 
                       
Total assets
         
344,147
     
287,908
 
                       
Liabilities and shareholders’ equity
                     
                       
Current liabilities
                     
Trade accounts payable
         
32,980
     
27,180
 
Other current liabilities
 
5F
 
   
48,348
     
30,204
 
                       
Total current liabilities
         
81,328
     
57,384
 
                       
Long term liabilities
                     
Deferred tax liabilities, net
         
186
     
-
 
Other long-term liabilities
         
3,470
     
3,260
 
           
3,656
     
3,260
 
                       
Total liabilities
         
84,984
     
60,644
 
                       
Shareholders’ equity
                     
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at June 30, 2021 and at December 31, 2020;
                     
45,804,862 issued shares at June 30, 2021 and 45,365,354 at December 31, 2020;
                     
43,712,486 shares outstanding at June 30, 2021 and 43,272,978 at December 31, 2020;
 
3
     
172
     
171
 
Additional paid-in capital
         
173,383
     
170,497
 
Retained earnings
         
87,506
     
58,494
 
           
261,061
     
229,162
 
Treasury stock, at cost (2,092,376 as of June 30, 2021 and December 31, 2020)
         
(1,898
)
   
(1,898
)
                       
Total shareholders' equity
         
259,163
     
227,264
 
                       
Total liabilities and shareholders' equity
         
344,147
     
287,908
 
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

 

F - 3


 
Camtek Ltd. and its Subsidiaries
Interim Unaudited Condensed Consolidated Statements of Operations

(In thousands, except per share data)
 
         
Six months ended
June 30,
   
Three months ended
June 30,
   
Year ended
December 31,
 
         
2021
   
2020
   
2021
   
2020
   
2020
 
   
Note
   
U.S. dollars
   
U.S. dollars
   
U.S. dollars
 
Revenues
 
4
     
124,802
     
67,179
     
67,450
     
37,000
     
155,859
 
Cost of revenues
         
60,831
     
36,679
     
32,456
     
20,057
     
82,628
 
                                               
Gross profit
         
63,971
     
30,500
     
34,994
     
16,943
     
73,231
 
                                               
Research and development costs
         
11,244
     
8,884
     
5,766
     
4,754
     
19,575
 
Selling, general and
                                             
 administrative expenses
 
6A
 
   
21,288
     
13,338
     
12,188
     
6,779
     
31,032
 
           
32,532
     
22,222
     
17,954
     
11,533
     
50,607
 
                                               
Operating income
         
31,439
     
8,278
     
17,040
     
5,410
     
22,624
 
                                               
Financial income, net
 
6B
 
   
562
     
651
     
176
     
276
     
775
 
                                               
Income from continuing
                                             
operations before taxes
         
32,001
     
8,929
     
17,216
     
5,686
     
23,399
 
                                               
Income tax expense
         
(2,989
)
   
(841
)
   
(1,564
)
   
(378
)
   
(1,621
)
                                               
Net income
         
29,012
     
8,088
     
15,652
     
5,308
     
21,778
 
                                               
Basic net earnings
         
0.67
     
0.21
     
0.36
     
0.14
     
0.55
 
                                               
Diluted net earnings
         
0.65
     
0.20
     
0.35
     
0.13
     
0.54
 
                                               
Weighted average number of
                                             
  ordinary shares outstanding
                                             
  (in thousands):
                                             
                                               
Basic
         
43,450
     
38,877
     
43,609
     
39,033
     
39,383
 
                                               
Diluted
         
44,612
     
39,785
     
44,750
     
39,945
     
40,372
 

The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

 

F - 4


 
Camtek Ltd. and its Subsidiaries
Interim Unaudited Condensed Consolidated Statements of Shareholders’ Equity

 
   
Ordinary Shares
   
Number of
          Additional          
Total
 
   
NIS 0.01 par value
   
Treasury
   
Treasury
   
paid-in
    Retained     shareholders'  
   
Number of
   
U.S. Dollars
   
Shares
   
capital
   
earnings
   
capital
   
equity
 
   
Shares Issued
   
(in thousands)
   
U.S. Dollars (in thousands)
 
                                           
Balances at
                                         
December 31, 2019
   
40,742,355
     
157
     
(2,092,376
)
   
(1,898
)
   
101,327
     
36,716
     
136,302
 
                                                         
Share-based
                                                       
 compensation
                                                       
 expense
   
-
     
-
     
-
     
-
     
817
     
-
     
817
 
Exercise of share
                                                       
 options
   
23,557
     
*
     
-
     
-
     
58
     
-
     
58
 
Net income
   
-
     
-
     
-
     
-
     
-
     
2,780
     
2,780
 
                                                         
Balances at
                                                       
March 31, 2020
   
40,765,912
     
157
     
(2,092,376
)
   
(1,898
)
   
102,202
     
39,496
     
139,957
 
                                                         
Share-based
                                                       
 compensation
                                                       
 expense
   
-
     
-
     
-
     
-
     
951
     
-
     
951
 
Exercise of share
                                                       
 options
   
358,802
     
1
     
-
     
-
     
275
     
-
     
276
 
Net income
   
-
     
-
     
-
     
-
     
-
     
5,308
     
5,308
 
                                                         
Balances at
                                                       
June 30, 2020
   
41,124,714
     
158
     
(2,092,376
)
   
(1,898
)
   
103,428
     
44,804
     
146,492
 
                                                         
Issuance of shares
   
4,025,000
     
12
     
-
     
-
     
64,308
     
-
     
64,320
 
Exercise of share
                                                       
 options
   
215,640
     
1
     
-
     
-
     
294
     
-
     
295
 
Share-based
                                                       
 compensation
                                                       
 expense
   
-
     
-
     
-
     
-
     
2,467
     
-
     
2,467
 
Net income
   
-
     
-
     
-
     
-
     
-
     
13,690
     
13,690
 
Balances at
                                                       
December 31, 2020
   
45,365,354
     
171
     
(2,092,376
)
   
(1,898
)
   
170,497
     
58,494
     
227,264
 
                                                         
Share-based
                                                       
 compensation
                                                       
 expense
   
-
     
-
     
-
     
-
     
1,211
     
-
     
1,211
 
Exercise of share
                                                       
 options
   
57,227
     
*
     
-
     
-
     
161
     
-
     
161
 
Net income
   
-
     
-
     
-
     
-
     
-
     
13,360
     
13,360
 
                                                         
Balances at
                                                       
March 31, 2021
   
45,422,581
     
171
     
(2,092,376
)
   
(1,898
)
   
171,869
     
71,854
     
241,996
 
                                           
Share-based
                                         
 compensation
                                         
 expense
   
-
     
-
     
-
     
-
     
1,470
     
-
     
1,470
 
Exercise of share
                                                       
 options
   
382,281
     
1
     
-
     
-
     
44
     
-
     
45
 
Net income
   
-
     
-
     
-
     
-
     
-
     
15,652
     
15,652
 
                                                         
Balances at
                                                       
June 30, 2021
   
45,804,862
     
172
     
(2,092,376
)
   
(1,898
)
   
173,383
     
87,506
     
259,163
 
 
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

 

F - 5


 
Camtek Ltd. and its Subsidiaries
Interim Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)
 
   
Six months ended
June 30,
   
Three months ended
June 30,
   
Year ended
December 31,
 
   
2021
   
2020
   
2021
   
2020
   
2020
 
   
U.S. dollars
   
U.S. dollars
   
U.S. dollars
 
                               
Cash flows from operating activities:
                             
Net income
   
29,012
     
8,088
     
15,652
     
5,308
     
21,778
 
Adjustments to reconcile net income to net
  cash provided by operating activities:
                                       
Depreciation and amortization
   
1,278
     
1,057
     
648
     
531
     
2,234
 
Deferred tax expense
   
668
     
226
     
60
     
296
     
476
 
Loss on disposal of fixed assets
   
31
     
-
     
11
     
-
     
-
 
Share based compensation expense
   
2,681
     
1,768
     
1,470
     
951
     
4,235
 
Change in provision for doubtful debts
   
(33
)
   
-
     
-
     
-
     
(87
)
                                         
Changes in operating assets and liabilities:
                                       
Trade accounts receivable, gross
   
(19,234
)
   
(8,108
)
   
(6,115
)
   
(2,355
)
   
(9,696
)
Inventories
   
(15,182
)
   
(7,014
)
   
(9,825
)
   
(3,991
)
   
(19,330
)
Due from related parties, net
   
(12
)
   
20
     
(2
)
   
51
     
72
 
Other assets
   
(1,067
)
   
(601
)
   
(505
)
   
(529
)
   
(501
)
Trade accounts payable
   
6,040
     
9,219
     
5,809
     
4,247
     
15,661
 
Other current liabilities
   
18,397
     
7,765
     
12,653
     
6,569
     
10,686
 
Liability for employee severance benefits, net
   
43
     
46
     
36
     
48
     
224
 
                                         
  Net cash provided by operating activities
   
22,622
     
12,466
     
19,892
     
11,126
     
25,752
 
                                         
Cash flows from investing activities:
                                       
Release from (investment in) short-term deposits
   
(37,000
)
   
(17,500
)
   
6,000
     
(27,500
)
   
(20,500
)
Release from (investment in) long-term deposits
   
(10,000
)
   
-
     
-
     
-
     
-
 
Purchase of fixed assets
   
(1,268
)
   
(775
)
   
(802
)
   
(365
)
   
(2,410
)
Purchase of intangible assets
   
(45
)
   
(126
)
   
(13
)
   
(122
)
   
(216
)
                                         
Net cash provided by (used in) investing activities
   
(48,313
)
   
(18,401
)
   
5,185
     
(27,987
)
   
(23,126
)
Cash flows from financing activities:
                             
Share issuance, net
   
-
     
-
     
1
     
-
     
64,288
 
Proceeds from exercise of share options
   
206
     
334
     
44
     
276
     
629
 
                                         
Net cash provided by financing activities
   
206
     
334
     
45
     
276
     
64,917
 
Effect of change in exchange rate on cash and cash equivalents
   
9
     
23
     
270
     
(32
)
   
225
 
                                         

Net increase (decrease) in cash and cash
  equivalents

   
(25,476
)
   
(5,578
)
   
25,392
     
(16,617
)
   
67,768
 
Cash and cash equivalents at beginning of
   
 the period
   
105,815
     
38,047
     
54,947
     
49,086
     
38,047
 
                                         
 Cash and cash equivalents at end of the
     
period
   
80,339
     
32,469
     
80,339
     
32,469
     
105,815
 
                               
Supplementary cash flows information:
                             
Income taxes paid
   
153
     
211
     
44
     
12
     
546
 
  Lease payments
   
481
     
530
     
239
     
260
     
1,025
 
                               
Non-cash transactions:
                             
Fixed assets purchased with supplier credit
   
321
     
162
     
321
     
162
     
159
 
 
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

 

F - 6


 
Camtek Ltd. and its Subsidiaries
Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)
 
Note 1 - Nature of Operations
 
  A.
Camtek Ltd. (“Camtek” or the “Company”), an Israeli corporation, is jointly controlled 21.0% by Priortech Ltd., an Israeli corporation listed on the Tel-Aviv Stock Exchange and 17.9% by Chroma Ate Inc., a Taiwanese company (“Chroma”). Camtek provides automated and technologically advanced solutions dedicated to enhancing production processes, increasing product yield and reliability, and enabling and supporting customers’ latest technologies in the semiconductor fabrication industry.
 
  B.
As detailed in the annual financial statements as of December 31, 2020, since January 2020, the Covid-19 outbreak has dramatically expanded into a worldwide pandemic creating macro-economic uncertainty and disruption in the business and financial markets. At present, business activity is continuing at all of the Company’s locations, with new routines implemented as required by local Covid-19 regulations.
 
From the beginning of the outbreak, the Company has been carefully managing the risks and its global operations. The Israeli facility has been able to maintain its required production levels. Worldwide, the Company has benefitted from its strategy of having in place local professional teams in each of its territories that can independently install and support systems. As such, the Company has been able to deliver most of its orders on time and the impact of the Covid-19 pandemic on the its business activity has not been significant.

 

F - 7


 

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

 
Note 2 - Basis of Preparation
 
A.          Statement of compliance
 
Except as described below, the accounting policies applied in these interim financial statements are the same as those applied in the Company’s 2020 annual audited consolidated financial statement for the year ended December 31, 2020.
 
The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and do not include all of the information required for full annual financial statements. The unaudited condensed consolidated interim statements should be read in conjunction with the Company’s 2020 annual audited consolidated financial statements and footnotes, which were filed with the U.S. Securities and Exchange Commission as part of the Company’s Annual Report on Form 20-F for the year ended December 31, 2020.
 
In the opinion of management of the Company, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six-month periods ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ended December 31, 2021 or for any other future period.

 

B.          Recent Accounting Pronouncements
 
In December 2019, the FASB issued Accounting Standard Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance became effective in the first quarter of 2021 on a prospective basis. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

 

F - 8


 

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

 
Note 3 - Shareholders’ Equity
 
A.          General

 

The Company’s shares are traded on the NASDAQ Global Market under the symbol “CAMT”, and also listed and traded on the Tel-Aviv stock exchange

 

B.          Changes in Stock Options and RSUs

 

The number of stock options exercised in the three-month and six-month periods ended June 30, 2021, were 382,201 and 439,508, respectively.

 

In the first six months of 2021, 166,400 restricted share units (RSUs) were granted by the Company. The RSUs vest over a four-year period.
 
C.          Share-based Compensation Expense
 
The total share-based compensation expense amounted to $2,681, $1,768, $1,470, $951 and $4,235 for the six-month periods ended June 30, 2021 and 2020, the three-month periods ended June 30, 2021 and 2020 and the year ended December 31, 2020, respectively.
 
Note 4 – Segment Information
 
Substantially all fixed assets are located in Israel and substantially all revenues are derived from shipments to other countries. Revenues are attributable to geographic areas/countries based upon the destination of shipment of products and related services as follows:
 
   
Six months ended
June 30,
   
Three months ended
June 30,
   
Year ended
December 31,
 
   
2021
   
2020
   
2021
   
2020
   
2020
 
   
U.S. Dollars (in thousands)
 
                               
Asia Pacific
   
109,345
     
61,914
     
59,145
     
35,130
     
137,555
 
United States
   
8,827
     
3,258
     
4,446
     
986
     
9,847
 
Europe
   
6,630
     
2,007
     
3,859
     
884
     
8,457
 
                                         
     
124,802
     
67,179
     
67,450
     
37,000
     
155,859
 

 

F - 9


 

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

 
Note 5 - Supplementary Financial Statements Information
 
A.          Cash and cash equivalents

 

The Company’s cash and cash equivalent balance at June 30, 2021 and December 31, 2020 is denominated in the following currencies:
 
   
June 30,
   
December 31,
 
   
2021
   
2020
 
   
U.S. Dollars (in thousands)
 
             
US Dollars
   
64,649
     
102,669
 
New Israeli Shekels
   
13,344
     
1,542
 
Euro
   
1,221
     
570
 
Other currencies
   
1,125
     
1,034
 
                 
     
80,339
     
105,815
 
 
B.          Inventories
 
   
June 30,
   
December 31,
 
   
2021
   
2020
 
   
U.S. Dollars (in thousands)
 
             
Components
   
27,907
     
19,630
 
Work in process
   
11,317
     
10,123
 
Finished products (including systems at customer locations not yet sold)
   
19,816
     
14,399
 
                 
     
59,040
     
44,152
 

 

Inventories are presented in:
 
   
June 30,
   
December, 31
 
   
2021
   
2020
 
   
U.S. Dollars (in thousands)
 
             
Current assets
   
54,346
     
39,736
 
Long-term assets
   
4,694
     
4,416
 
                 
     
59,040
     
44,152
 

 

F - 10


 

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

 

Note 5 - Supplementary Financial Statements Information (cont’d)

 
C.          Other Current Assets
 
   
June 30,
   
December 31,
 
   
2021
    2020  
   
U.S. Dollars (in thousands)
 
             
Due from Government institutions
   
2,382
     
1,967
 
Interest receivable
   
368
     
207
 
Prepaid expenses
   
1,144
     
455
 
Income tax receivables
   
307
     
302
 
Deposits for operating leases
   
123
     
195
 
Other
   
87
     
240
 
                 
     
4,411
     
3,366
 

 

D.          Property, Plant and Equipment, Net
 
   
June 30,
   
December, 31
 
   
2021
   
2020
 
   
U.S. Dollars (in thousands)
 
             
Land
   
863
     
863
 
Building
   
14,481
     
14,438
 
Machinery and equipment
   
11,772
     
11,260
 
Office furniture and equipment
   
846
     
785
 
Computer equipment and software
   
5,222
     
4,760
 
Automobiles
   
281
     
263
 
Leasehold improvements
   
680
     
630
 
Right of use assets
   
3,284
     
3,014
 
     
37,429
     
36,013
 
                 
Less accumulated depreciation
   
17,052
     
15,615
 
                 
     
20,377
     
20,398
 

 

F - 11


 

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

Note 5 - Supplementary Financial Statements Information (cont’d)

 

E.          Intangible Assets, Net
 
   
June 30,
   
December 31,
 
    2021    
2020
 
   
U.S. Dollars (in thousands)
 
             
Patent registration costs
   
1,972
     
1,927
 
                 
Accumulated amortization and impairment
   
1,370
     
1,318
 
                 
Total intangible assets, net
   
602
     
609
 

 

F.          Other Current Liabilities
 
   
June 30,
   
December 31,
 
   
2021
   
2020
 
   
U.S. Dollars (in thousands)
 
             
Commissions
   
14,286
     
7,965
 
Advances from customers and deferred revenues
   
12,900
     
6,155
 
Accrued employee compensation and related benefits
   
12,025
     
9,698
 
Accrued warranty costs
   
3,267
     
2,328
 
Government institutions
   
2,987
     
752
 
Accrued expenses
   
2,172
     
2,570
 
Operating lease obligations
   
711
     
736
 
                 
     
48,348
     
30,204
 

 

F - 12


 

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

 

Note 6 - Statements of Operations

 

  A.
Selling, general and administrative expenses
 
   
Six months ended
June 30,
   
Three months ended
June 30,
   
Year ended
December 31,
 
   
2021
   
2020
   
2021
   
2020
   
2020
 
   
U.S. Dollars (in thousands)
 
                               
Selling (1)
   
16,635
     
9,551
     
9,879
     
4,807
     
22,969
 
General and administrative
   
4,653
     
3,787
     
2,309
     
1,972
     
8,063
 
                                         
     
21,288
     
13,338
     
12,188
     
6,779
     
31,032
 
(1)       Including shipping and handling costs
   
840
     
1,137
     
378
     
672
     
2,356
 
 
B.       Financial income (expenses), net
 
   
Six months ended
June 30,
   
Three months ended
June 30,
   
Year ended
December 31,
 
   
2021
   
2020
   
2021
   
2020
   
2020
 
   
U.S. Dollars (in thousands)
 
                               
Interest income
   
561
     
730
     
323
     
344
     
1,281
 
Other, net (1)
   
1
     
(79
)
   
(147
)
   
(68
)
   
(506
)
                                         
     
562
     
651
     
176
     
276
     
775
 
(1)       Including foreign currency expense resulting from transactions not denominated in U.S. Dollars
   
151
     
(22
)
   
(66
)
   
(39
)
   
(351
)
 

F - 13